World leader in the development and manufacturing of nasal and pulmonary drug delivery devices, Aptar Pharma is ready to offer  its latest innovation, DF30Plus.  The metering valve is the result of continuous improvement to the already world leading DF30 technology platform.

The advanced features of the product are better compatibility across a wider range of drug formulations, including ethanol-containing formulations. Its design offers the much needed cost-effectiveness to the users. It also has an ultra low extractible level and  robust  design enables accurate and consistent performance. There is also excellent pressure filling capability.

The novel product was unveiled at the Drug Delivery to the Lungs (DDL) scientific conference, held in Edinburgh, Scotland, from December 7 to  9, 2011.

Aptar Pharma is the worldwide leader in aerosol metering valves for pMDIs for the treatment of asthma and COPD (constructive obstructive pulmonary disorder). The company’s  metering valves have been selected by major branded pharmaceutical companies and generic producers across the globe.  Each year, several hundred million metering valves are produced at the  Aptar’s GMP ISO7 clean rooms. The company is the only metering valve supplier that designs, develops and manufactures its own elastomer formulations and rubber gaskets which is a  key component of the valve, within its unique in-house Elastomer Centre. The  DF30 metering valve technology platform has been the industry gold standard for more than 20 years and we are constantly striving to optimize it.

According to Chris Baron, Associate Director, Business Development for Aptar Pharma Prescription Division,   DF30Plus is the result of innovation and continuous improvement to the DF30 technology platform range and provides several new benefits. After 20 years of leading the industry in the supply of metering valves for pMDIs, we still continue to improve our high quality devices and anticipate.

“Our customers’ future needs and expectations,” he added.

US-based Aptar Pharma with manufacturing sites in North America, Europe, Asia and South America, is  engaged in the development of innovative drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world. It offers a  wide range of delivery technologies and analytical services backed by years of proven expertise.